Cambrex VP Featured in Drug Delivery Technology Article
East Rutherford, NJ – Cambrex Corporation’s (NYSE: CBM, "Cambrex") Vice President of Drug Delivery, Dan Giambattisto, was featured in the July/August 2010 edition of Drug Delivery Technology magazine. The magazine interviewed Mr. Giambattisto for the Drug Delivery Executive feature article entitled Cambrex Corporation: Accelerating Development and Commercialization. The article covers many topics from the innovative products and technologies comprising Cambrex’s drug delivery business to the future of drug delivery technologies.
According to Mr. Giambattisto, “This interview allowed Cambrex to present the distinct characteristics of our Camouflage™ drug delivery technology as an enabling tool and the potential client and consumer benefits of using Cambrex’s drug delivery platform.”
According to their website, the digital and print magazine keeps its 20,000 readers abreast of the science and business of drug delivery through scientific papers, special news and market news.
Cambrex’s article in Drug Delivery Technology can be viewed on-line at: www.drugdeliverytech.com
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.